High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study

被引:60
作者
Sasso, Ferdinando C. [1 ,2 ]
Chiodini, Paolo [3 ]
Carbonara, Ornella [1 ,2 ]
De Nicola, Luca [4 ]
Conte, Giuseppe [4 ]
Salvatore, Teresa [1 ,2 ]
Nasti, Rodolfo [1 ,2 ]
Marfella, Raffaele [2 ]
Gallo, Ciro [3 ]
Signoriello, Simona [3 ]
Torella, Roberto [1 ,2 ]
Minutolo, Roberto [4 ]
机构
[1] Univ Naples 2, Dept Internal & Expt Med, Naples, Italy
[2] Univ Naples 2, Excellence Ctr Cardiovasc Dis, Naples, Italy
[3] Univ Naples 2, Dept Biostat, Naples, Italy
[4] Univ Naples 2, Dept Nephrol, Naples, Italy
关键词
albuminuria; cardiovascular; diabetic nephropathy; GFR; proliferative retinopathy; CORONARY-HEART-DISEASE; RENAL BIOPSY; RETINOPATHY; PREVENTION; MORTALITY; OUTCOMES;
D O I
10.1093/ndt/gfr644
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. In Type 2 diabetic patients, clinical diagnosis of diabetic nephropathy (DN) is generally based on the concomitant presence of abnormal albuminuria and severe retinopathy. In this high-risk population, cardiovascular (CV) outcome has never been evaluated. Methods. A cohort of 742 Type 2 diabetic patients with DN from 17 national centres was selected by the presence of persistent albuminuria >= 30 mg/day and severe diabetic retinopathy and was followed prospectively. Time to CV event (CV death, non-fatal myocardial infarction, non-fatal stroke, revascularization, major amputation) was the primary composite end point and it was analysed by multivariable Cox's proportional hazards model. The interaction between albuminuria and glomerular filtration rate (GFR) was specifically investigated. Results. Median follow-up was 4.6 years. Overall 242 events (26% of which fatal) were observed in 202 patients. The proportion of CV events increased from 19 to 40% as GFR declined from the highest (>= 90 mL/min/1.73m(2)) to the lowest (<45 mL/min/1.73m(2)) category and was equal to 25 and 33% in microalbuminuria and macroalbuminuria, respectively. In multivariable analysis, the interaction between albuminuria and GFR was statistically significant (P = 0.012). Albuminuria, indeed, had a remarkable prognostic effect in subjects with high GFR that virtually disappeared as GFR became <30 mL/min/1.73m(2). Age, smoking habit, previous occurrence of myocardial infarction or stroke and proliferative retinopathy were all found to have a statistically significant prognostic effect on CV outcome. Conclusions. A clinically based diagnosis of DN in Type 2 diabetes allows the identification of subjects with high CV risk. Albuminuria has a relevant prognostic effect on CV morbidity and mortality; its effect is especially pronounced when GFR is normal or near normal.
引用
收藏
页码:2269 / 2274
页数:6
相关论文
共 25 条
[1]   Long-term retinal, renal and cardiovascular outcomes in diabetic chronic kidney disease without proteinuria [J].
Agarwal, Rajiv ;
Debella, Yalew T. ;
Giduma, Habtamu D. ;
Light, Robert P. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (01) :310-317
[2]   The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease [J].
Ahmed, Aimun K. ;
Kamath, Neetha S. ;
El Kossi, Mohsen ;
El Nahas, A. Meguid .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (12) :3977-3982
[3]   Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].
Alpert, JS ;
Antman, E ;
Apple, F ;
Armstrong, PW ;
Bassand, JP ;
de Luna, AB ;
Beller, G ;
Breithardt, G ;
Chaitman, BR ;
Clemmensen, P ;
Falk, E ;
Fishbein, MC ;
Galvani, M ;
Garson, A ;
Grines, C ;
Hamm, C ;
Jaffe, A ;
Katus, H ;
Kjekshus, J ;
Klein, W ;
Klootwijk, P ;
Lenfant, C ;
Levy, D ;
Levy, RI ;
Luepker, R ;
Marcus, F ;
Näslund, U ;
Ohman, M ;
Pahlm, O ;
Poole-Wilson, P ;
Popp, R ;
Alto, P ;
Pyörälä, K ;
Ravkilde, J ;
Rehnquist, N ;
Roberts, W ;
Roberts, R ;
Roelandt, J ;
Rydén, L ;
Sans, S ;
Simoons, ML ;
Thygesen, K ;
Tunstall-Pedoe, H ;
Underwood, R ;
Uretsky, BF ;
Van de Werf, F ;
Voipio-Pulkki, LM ;
Wagner, G ;
Wallentin, L ;
Wijns, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :959-969
[4]  
[Anonymous], 2002, Diabetes care, V25, pS1
[5]   Disease-dependent mechanisms of albuminuria [J].
Comper, Wayne D. ;
Hilliard, Lucinda M. ;
Nikolic-Paterson, David J. ;
Russo, Leileata M. .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2008, 295 (06) :F1589-F1600
[6]   ALBUMINURIA REFLECTS WIDESPREAD VASCULAR DAMAGE - THE STENO HYPOTHESIS [J].
DECKERT, T ;
FELDTRASMUSSEN, B ;
BORCHJOHNSEN, K ;
JENSEN, T ;
KOFOEDENEVOLDSEN, A .
DIABETOLOGIA, 1989, 32 (04) :219-226
[7]   Patterns of renal injury in NIDDM patients with microalbuminuria [J].
Fioretto, P ;
Mauer, M ;
Brocco, E ;
Velussi, M ;
Frigato, F ;
Muollo, B ;
Sambataro, M ;
Abaterusso, C ;
Baggio, B ;
Crepaldi, G ;
Nosadini, R .
DIABETOLOGIA, 1996, 39 (12) :1569-1576
[8]   Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes [J].
Gaede, P ;
Vedel, P ;
Larsen, N ;
Jensen, GVH ;
Parving, H ;
Pedersen, O .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (05) :383-393
[9]   The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis [J].
Gerstein, HC ;
Pogue, J ;
Mann, JFE ;
Lonn, E ;
Dagenais, GR ;
McQueen, M ;
Yusuf, S .
DIABETOLOGIA, 2005, 48 (09) :1749-1755
[10]   Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis [J].
Jennings, D. L. ;
Kalus, J. S. ;
Coleman, C. I. ;
Manierski, C. ;
Yee, J. .
DIABETIC MEDICINE, 2007, 24 (05) :486-493